Stock Events

Stock Events

Renalytix 

$2.71
28
-$0.06-1.99% Friday 19:00

Statistics

Day High
2.55
Day Low
2.55
52W High
202.5
52W Low
0.999
Volume
2
Avg. Volume
6,295
Mkt Cap
1.18B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3NovExpected
Q3 2024
Q3 2024
Q4 2024
Q1 2025
Q3 2025
Q4 2025
Next
-0.04
-0.03
-0.02
-0.02
Expected EPS
N/A
Actual EPS
N/A

Financials

-680%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
3MRevenue
-20.4MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RNLXY. It's not an investment recommendation.
Legal & General Group
4
LGEN.LSE
Standard Life
4
SDLF.LSE
Taylor Wimpey
4
TW.LSE
Lloyds Banking Group
3
LLOY.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bio-Rad Laboratories
BIO
Mkt Cap9.53B
Bio-Rad Laboratories offers a range of products for the clinical diagnostics market, competing in the same space as Renalytix's kidney diagnostic solutions.
Quest Diagnostics
DGX
Mkt Cap25.87B
Quest Diagnostics provides diagnostic testing, information, and services, including for kidney function, directly competing with Renalytix's offerings.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America Holdings operates in the same clinical laboratory services sector, offering tests that overlap with Renalytix's kidney health diagnostics.
Guardant Health
GH
Mkt Cap21.1B
Guardant Health operates in the precision oncology field but competes with Renalytix through its development of diagnostics that could overlap with kidney disease detection.
Fulgent Genetics
FLGT
Mkt Cap510.68M
Fulgent Genetics provides comprehensive genetic testing, directly competing in the genetic markers space for diseases, including those related to the kidney.
QuidelOrtho
QDEL
Mkt Cap980.63M
QuidelOrtho Corporation is a provider of diagnostic testing solutions that compete with Renalytix by offering tests that can be used in diagnosing kidney conditions.
Neogenomics
NEO
Mkt Cap2.05B
NeoGenomics specializes in cancer diagnostics and testing services but competes with Renalytix by offering tests that could be relevant for kidney disease patients.
Thermo Fisher Scientific
TMO
Mkt Cap217.52B
Thermo Fisher Scientific offers a wide range of healthcare solutions, including diagnostics that compete with Renalytix's kidney disease diagnostic products.

About

RENALYTIX PLC SP/ADR
Show more...
CEO
Mr. James R. McCullough M.B.A.
Country
United Kingdom
ISIN
US75973T2006
WKN
000A41WQD

Listings

F
DE
2O90.F
OTC Link
US
RENXF
MU
DE
2O90.MU
MU
DE
2O9A.MU

0 Comments

Share your thoughts

FAQ

What is Renalytix stock price today?▼
The current price of RNLXY is $2.71 USD — it has decreased by -1.99% in the past 24 hours. Watch Renalytix stock price performance more closely on the chart.
What is Renalytix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Renalytix stocks are traded under the ticker RNLXY.
Is Renalytix stock price growing?▼
RNLXY stock has fallen by -2.34% compared to the previous week, the month change is a +35.5% rise, over the last year Renalytix has showed a -29.52% decrease.
What is Renalytix market cap?▼
Today Renalytix has the market capitalization of 1.18B
When is the next Renalytix earnings date?▼
Renalytix is going to release the next earnings report on November 03, 2026.
What is Renalytix revenue for the last year?▼
Renalytix revenue for the last year amounts to 3M USD.
What is Renalytix net income for the last year?▼
RNLXY net income for the last year is -20.4M USD.
In which sector is Renalytix located?▼
Renalytix operates in the Other sector.
When did Renalytix complete a stock split?▼
The last stock split for Renalytix was on December 16, 2025 with a ratio of 1:25.
Where is Renalytix headquartered?▼
Renalytix is headquartered in London, United Kingdom.